Leave A Message

Leave A Message

If you are interested in our products and want to know more details,please leave a message here,we will reply you as soon as we can.
submit
banner
Company News
Home News Company News

Multimodality OCT System Cornaris P80 Debuts at Chilean Cardiovascular Academic Conference

Multimodality OCT System Cornaris P80 Debuts at Chilean Cardiovascular Academic Conference

Dec 12, 2024

The LX Congreso Chileno de Cardiología y Cirugía Cardiovascular represents a distinguished academic forum, convening preeminent physicians from across the globe. This esteemed conference serves as a pivotal platform for the dissemination of the latest advancements in cardiology, and this year, it notably featured pioneering technology from China.

 

Unveiling Vivolight’s Cornaris P80 by Vivolight

 

One of the standout moments of the conference was the unveiling of the Vivolight’s Cornaris P80 Optical Coherence Tomography (OCT) system, developed by Vivolight Medical from China. Presented by Dr. Bartolome Finizola, the Vivolight’s Cornaris P80 represents a significant milestone as the first multimodal OCT imaging system from China approved for commercial use. This innovation sets a new standard in high-resolution intravascular imaging, revolutionizing the field of cardiovascular diagnostics.

 

Transformative OCT-FFR Functionality

 

The Vivolight’s Cornaris P80's integrated with OCT-FFR feature represents a groundbreaking advancement in the field. By leveraging OCT pullback data, the system can accurately derive OCT-FFR (Optical Coherence Tomography based Fractional Flow Reserve), providing critical guidance for Percutaneous Coronary Intervention (PCI) procedures.

 

Dr. Bartolome Finizola also presented the latest data from a multicenter prospective clinical study recently finished in China. This comprehensive study involved multiple leading medical centers and evaluated the accuracy and efficacy of the OCT-FFR in real-world clinical settings. The results underscored the OCT-FFR feature’s exceptional performance and its potential to significantly improve patient outcomes in cardiovascular care. This innovation has garnered widespread acclaim within the medical community for its precision and operational efficiency.

 

Vivolight Medical: Pioneering Enterprise in Innovative Laser-based Interventional Medical Devices

 

Established in 2012, Vivolight Medical is a leading medical device company with its headquarters in Shenzhen and a R&D hub in Xi'an. Specializing in the domain of medical laser technology, we are dedicated to the independent research, development, and manufacturing of cutting-edge medical devices for minimally invasive interventional diagnostics and treatments. Our commitment to global innovation is evident in our fusion of world-class photoelectric technology with medical and engineering disciplines.

 

We have achieved comprehensive mastery over the core foundational technologies that underpin laser diagnostics and therapeutics, fiber-optic catheters, and image processing. This expertise has enabled us to develop an integrated "diagnosis and treatment" hard technology platform capable of addressing a multitude of disease categories.

 

Our product portfolio is extensive, encompassing a variety of applications, including but not limited to cardiovascular and peripheral vascular diseases. Several of our products have not only met but have also exceeded the standards set by global leaders in terms of technological innovation and clinical efficacy.

 

 

Multimodality Integration and Technological Innovation

 

Vivolight’s Cornaris P80 stands out with its unique multimodal integration, offering high-resolution imaging that enhances safety and efficiency during PCI procedures. Key features include:

 

  • Auto assessment of plaque stability for PCI strategy selection without extra cost and time.
  •  OCT-FFR, functional assessment of coronary arteries simultaneously with OCT examination, eliminating the need for additional expenses and time.
  •  Intelligent Calcium Assessment,automatic identification and calculation of calcium volume and score, simplifying the treatment of calcified lesions.
  • Ultra-long pullback of 80 mm in 2 seconds, High-definition scan of 55 mm in 2.75 seconds, and super-fast pullback of 40 mm in 1 second.
  • Auto-calculation of stent Neointimal Coverage rate to guide DAPT adjustment in PCI follow-up.

 

Celebrating Technological Innovation

 

The Vivolight’s Cornaris P80 by Vivolight transcends its role as a mere medical device; it exemplifies the transformative potential of innovation in the realm of cardiovascular care. As we celebrate this remarkable achievement at the LX Congreso Chileno de Cardiología y Cirugía Cardiovascular, we eagerly anticipate a future where the synergy of technology and medicine continues to elevate patient care standards on a global scale.

Leave A Message

Leave A Message
If you are interested in our products and want to know more details,please leave a message here,we will reply you as soon as we can.
submit

Home

products

whatsApp

contact